MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Bioventus Inc. Class A Common Stock

BVS

#2411
Bioventus Inc. Class A Common Stock
8.78
-1.13%
Sector:
Base:
Profit Currency:
Daily Range
8.78
8.78
Year Range
6.02
11.26
Daily Change
-1.13%
Monthly Change
+10.58%
6 month change
+17.07%
Year Change
-7.68%
Previous Close
8.88
Open
8.78
Bid
Ask
Low
8.78
High
8.78
Volume
111
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. BVS
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM

News

Investing Investing
BVS
2026.02.10
Bravura Solutions 1H26 presentation: Revenue up 9.8%, guidance upgraded
Investing Investing
BVS
2026.02.10
Earnings call transcript: Bravura Solutions’ H1 2026 highlights revenue growth
Seeking Alpha Seeking Alpha
BVS
2026.01.15
Bioventus Inc. (BVS) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:BVS) 2026-01-15
Seeking Alpha Seeking Alpha
BVS
2026.01.14
Bioventus Inc. (BVS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Seeking Alpha Seeking Alpha
BVS
2025.12.05
Bioventus Inc. (BVS) Presents at Piper Sandler 37th Annual Healthcare Conference - Slideshow (NASDAQ:BVS) 2025-12-04
Investing Investing
LAZ SNN BVS
2025.11.17
Bioventus appoints Ajay Dhankhar to board as Class II director
Investing Investing
EXPD WAT LUMN MU UNM
2025.11.04
Palantir, Uber among market cap stock movers on Tuesday
Investing Investing
BVS
2025.11.04
Bioventus Q3 2025 slides: 8% organic growth with margins expanding despite flat revenue
Investing Investing
BVS
2025.11.04
Bioventus tops Q3 expectations as organic revenue grows 8%
Investing Investing
BVS
2025.08.11
Cantor Fitzgerald reiterates Overweight rating on Bioventus stock
Zacks Zacks
BVS CASI
2025.08.06
Bioventus (BVS) Misses Q2 Earnings and Revenue Estimates
Investing Investing
BVS
2025.08.06
Bioventus Q2 2025 slides: 6% organic growth despite revenue dip, FDA clearance boosts outlook

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd